Enoxaparin Sodium Injection
Product Images NDC 68083-638

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68083-638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin-spl-blister-label-100mg (Enoxaparin Spl Blister Label 100mg)

Label for Enoxaparin Sodium Injection, USP 100 mg/mL in a single 1 mL syringe with automatic safety device. It is for subcutaneous injection and manufactured by Gland Pharma Limited. Storage instructions and dosage administration notes are provided, along with a barcode and peelable batch detail section.*

FDA Label Image

Enoxaparin-spl-blister-label-120mg (Enoxaparin Spl Blister Label 120mg)

Enoxaparin Sodium Injection, USP 120 mg/0.8 mL single-dose syringe label with automatic safety device. The label states subcutaneous injection route and storage instructions at 20° to 25°C. Manufactured by Gland Pharma Limited, Hyderabad, India. Includes barcode and lot/expiration area for batch details.*

FDA Label Image

Enoxaparin-spl-blister-label-150mg (Enoxaparin Spl Blister Label 150mg)

Enoxaparin Sodium Injection, USP 150 mg/mL in a single-dose syringe with automatic safety device, intended for subcutaneous injection. The label indicates one 1 mL syringe. Manufactured by Gland Pharma Limited. Includes storage instructions and a barcode. The label shows NDC 68083-640-01 and batch detail peel area with lot and expiry dates.*

FDA Label Image

Enoxaparin-spl-blister-label-30 mg (Enoxaparin Spl Blister Label 30 mg)

Label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL in a single-dose syringe with automatic safety device. The product is for subcutaneous injection and is manufactured by Gland Pharma Limited in Hyderabad, India. The label includes storage instructions, warnings, and a barcode.*

FDA Label Image

Enoxaparin-spl-blister-label-40-mg (Enoxaparin Spl Blister Label 40 mg)

Label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL in a single dose syringe with automatic safety device. The label indicates subcutaneous injection use and includes manufacturer information for Gland Pharma Limited, Hyderabad, India. The label also contains storage instructions, a barcode, and placeholders for batch lot and expiration date.*

FDA Label Image

Enoxaparin-spl-blister-label-60mg (Enoxaparin Spl Blister Label 60mg)

Label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL single dose syringe with automatic safety device. Intended for subcutaneous injection, manufactured by Gland Pharma Limited in Hyderabad, India. Includes storage instructions, dosage measurement details, bar code, and peel section for batch and expiration details.*

FDA Label Image

Enoxaparin-spl-blister-label-80mg (Enoxaparin Spl Blister Label 80mg)

Label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL single dose syringe. The label indicates it is for subcutaneous injection and includes a barcode, storage instructions (20° to 25°C), and manufacturer information for Gland Pharma Limited, Hyderabad, India. The label also notes the syringe has an automatic safety device.*

FDA Label Image

Enoxaparin-spl-carton-100mg (Enoxaparin Spl Carton 100mg)

Enoxaparin Sodium Injection, USP 100 mg/mL single dose syringe packaging label from Gland Pharma Limited. Includes directions for use with an automatic safety device and instructions for subcutaneous injection. The label displays product name, strength, dosage form, and handling instructions, along with manufacturer and storage information. Package contains 10 single dose 1 mL syringes.*

FDA Label Image

Enoxaparin-spl-carton-120mg (Enoxaparin Spl Carton 120mg)

Packaging label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL subcutaneous injection by Gland Pharma Limited. The label shows a single-dose syringe with automatic safety device, sterile, with 10 syringes per package. Includes directions for use and storage instructions, along with NDC 68083-639-10 and a barcode.*

FDA Label Image

Enoxaparin-spl-carton-150mg (Enoxaparin Spl Carton 150mg)

Box packaging label for Enoxaparin Sodium Injection, USP 150 mg/mL by Gland Pharma Limited. The label indicates single-dose syringes with automatic safety devices, for subcutaneous injection. It includes directions for use with illustrations, dosage information, the NDC 68083-640-10, storage instructions, and manufacturer details in India.*

FDA Label Image

Enoxaparin-spl-carton-30 mg (Enoxaparin Spl Carton 30 mg)

Packaging label for Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL single dose syringes with automatic safety device. The label includes directions for use, dosage form as subcutaneous injection, and states the product is sterile. Manufactured by Gland Pharma Limited. The label features the NDC 68083-634-10 and Rx only designation.*

FDA Label Image

Enoxaparin-spl-carton-40-mg (Enoxaparin Spl Carton 40 mg)

Packaging label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL by Gland Pharma Limited. The package contains 10 single-dose syringes with an automatic safety device for subcutaneous injection. The label includes directions for use, storage instructions, and manufacturer information with highlighted product strength and dosage form.*

FDA Label Image

Enoxaparin-spl-carton-60mg (Enoxaparin Spl Carton 60mg)

Packaging label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL by Gland Pharma Limited. The label indicates single dose syringes with an automatic safety device for subcutaneous injection. The package contains 10 syringes of 0.6 mL each. Directions for use with illustrations and product warnings are also present on the label. The design features an orange band across the top portion.*

FDA Label Image

Enoxaparin-spl-carton-80mg (Enoxaparin Spl Carton 80mg)

Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL by Gland Pharma Limited. The label is for a single dose syringe with an automatic safety device, containing 10 x 0.8 mL syringes for subcutaneous injection. The label includes usage instructions and storage information, and features a barcode and NDC 68083-637-10.*

FDA Label Image

Enoxaparin-spl-figure1 (Enoxaparin Spl Figure1)

An instructional illustration showing two hands with arrows between them, indicating a pull-apart motion. The image suggests separating two components or parts, likely related to preparing the ENOXAPARIN SODIUM injection for use.*

FDA Label Image

Enoxaparin-spl-figure10 (Enoxaparin Spl Figure10)

An instructional line drawing labeled Figure B showing two hands opening a blister pack containing a prefilled syringe. One hand peels back the protective foil covering the syringe, while the other hand holds the syringe inside the blister tray.*

FDA Label Image

Enoxaparin-spl-figure11 (Enoxaparin Spl Figure11)

An instructional illustration labeled Figure C depicts a syringe with a plunger and needle cap. The image highlights the location of the expiration date on the syringe barrel, indicated by an arrow pointing to the printed area.*

FDA Label Image

Enoxaparin-spl-figure12 (Enoxaparin Spl Figure12)

An instructional illustration showing a disposable syringe filled with a clear liquid, labeled as 'Clear Liquid.' The syringe has a plunger and is designed for subcutaneous injection.*

FDA Label Image

Enoxaparin-spl-figure13 (Enoxaparin Spl Figure13)

Illustration showing the lower back area with two shaded rectangles indicating possible injection sites for subcutaneous administration of Enoxaparin Sodium injection.*

FDA Label Image

Enoxaparin-spl-figure14 (Enoxaparin Spl Figure14)

An instructional line drawing showing a hand holding a small square or rectangular object against the lower abdomen area of a human torso, demonstrating a step likely related to subcutaneous injection or application technique.*

FDA Label Image

Enoxaparin-spl-figure15 (Enoxaparin Spl Figure15)

An instructional line drawing showing two hands preparing an injection. The left hand holds a needle cap, and the right hand holds a syringe. Double-headed arrows between them indicate the action of removing or attaching the needle cap prior to injection.*

FDA Label Image

Enoxaparin-spl-figure16 (Enoxaparin Spl Figure16)

An instructional diagram showing a hand pressing down on the plunger of a syringe, indicating the action to set the dose for an injection. The syringe is shown with measurement markings and an arrow pointing downward to illustrate dose adjustment.*

FDA Label Image

Enoxaparin-spl-figure17 (Enoxaparin Spl Figure17)

An instructional diagram labeled Figure 1 showing a hand pinching the skin on the abdominal area, commonly used to demonstrate proper technique for subcutaneous injection site preparation.*

FDA Label Image

Enoxaparin-spl-figure18 (Enoxaparin Spl Figure18)

An instructional diagram showing the proper technique for administering a subcutaneous injection using a syringe. The image depicts one hand stabilizing the injection site while the other hand inserts the needle at a 90-degree angle into the skin, with an arrow indicating the direction of the injection.*

FDA Label Image

Enoxaparin-spl-figure19 (Enoxaparin Spl Figure19)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the abdomen region. Another hand is placed on the skin, pinching it to prepare for the injection.*

FDA Label Image

Enoxaparin-spl-figure2 (Enoxaparin Spl Figure2)

An instructional illustration showing hands holding a syringe with an arrow pointing downward, demonstrating withdrawal of fluid or preparation of an injection dose, related to ENOXAPARIN SODIUM injection.*

FDA Label Image

Enoxaparin-spl-figure20 (Enoxaparin Spl Figure20)

An instructional line drawing showing a hand preparing to inject a subcutaneous injection into the abdomen of a person. The syringe is positioned perpendicular to the skin, indicating the injection technique.*

FDA Label Image

Enoxaparin-spl-figure21 (Enoxaparin Spl Figure21)

An instructional illustration showing a hand holding a syringe with a protective sleeve. The image includes an arrow pointing to the syringe plunger with the word 'CLICK,' indicating a step in using the syringe, likely related to preparing or activating the injection device for use.*

FDA Label Image

Enoxaparin-spl-figure22 (Enoxaparin Spl Figure22)

Illustration showing a hand disposing an Enoxaparin Sodium injection syringe by removing the needle cap and placing the syringe into a sharps disposal container labeled 'Sharps Disposal Container'.*

FDA Label Image

Enoxaparin-spl-figure3 (Enoxaparin Spl Figure3)

Illustration labeled 'Figure C' showing a hand holding a syringe positioned for a subcutaneous injection, with an arrow indicating the injection direction into the skin.*

FDA Label Image

Enoxaparin-spl-figure4 (Enoxaparin Spl Figure4)

An instructional illustration showing a hand holding a syringe labeled 'Figure D.' The image demonstrates a step involving movement of the thumb in an upward direction, indicated by an arrow, likely related to preparing or administering an injection.*

FDA Label Image

Enoxaparin-spl-figure5 (Enoxaparin Spl Figure5)

An instructional illustration labeled Figure E depicts a hand disposing of a syringe into a container marked BIOHAZARD. A bold downward arrow indicates the correct disposal direction, emphasizing safe discarding of injection materials.*

FDA Label Image

Enoxaparin-spl-figure6 (Enoxaparin Spl Figure6)

A forest plot chart depicting relative risk comparisons between Unfractionated Heparin (UFH) and Enoxaparin (Enox) across patient subgroups categorized by sex, age, infarct location, diabetes status, prior myocardial infarction (MI), fibrinolytic agent type, time to treatment, and PCI within 30 days. The chart includes the number of patients per subgroup, relative risk points with confidence intervals, percentages for UFH and Enox, and reduction in risk values, showing overall relative risk and individual subgroup outcomes.*

FDA Label Image

Enoxaparin-spl-figure7 (Enoxaparin Spl Figure7)

A hazard distribution function plot comparing Enoxaparin and UFH over time to death or myocardial re-infarction in days, with Enoxaparin showing a lower hazard than UFH. The chart includes a smaller inset graph showing the comparison at one year. Below the graph is a table indicating the number of patients at risk for each treatment group over time.*

FDA Label Image

Enoxaparin-spl-figure8 (Enoxaparin Spl Figure8)

An instructional diagram showing the components of an Enoxaparin Sodium injection syringe before and after use. The before-use syringe illustration labels the plunger rod, needle, and needle cap, while the after-use syringe includes the plunger rod and a protective sleeve covering the needle.*

FDA Label Image

Enoxaparin-spl-figure9 (Enoxaparin Spl Figure9)

An instructional illustration showing components for Enoxaparin Sodium subcutaneous injection administration. The diagram labels a prefilled Enoxaparin sodium syringe, a sharps disposal container, one cotton ball or gauze, one alcohol wipe, and one small adhesive bandage.*

FDA Label Image

Enoxaparin-spl-pfs-label-100mg (Enoxaparin Spl Pfs Label 100mg)

Label for Enoxaparin Sodium Injection, USP 100 mg/mL, for subcutaneous injection. The label includes the NDC number 68083-638-01 and states it is manufactured by Gland Pharma Limited. There is a designated unvarnished area for batch details and expiration date, alongside a barcode.*

FDA Label Image

Enoxaparin-spl-pfs-label-120mg (Enoxaparin Spl Pfs Label 120mg)

Label of Enoxaparin Sodium Injection USP 120 mg/0.8 mL for subcutaneous injection. The label indicates the product is manufactured by Gland Pharma Limited. It includes NDC 68083-639-01, lot and expiration placeholders, and a barcode on the right side.*

FDA Label Image

Enoxaparin-spl-pfs-label-150mg (Enoxaparin Spl Pfs Label 150mg)

Label for Enoxaparin Sodium Injection, USP 150 mg/mL, for subcutaneous injection. The label includes the National Drug Code (NDC) 68083-640-01, manufacturer Gland Pharma Limited, and space for lot and expiration details. A barcode is visible on the right side of the label.*

FDA Label Image

Enoxaparin-spl-pfs-label-30 mg (Enoxaparin Spl Pfs Label 30 mg)

Label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL, a subcutaneous injection manufactured by Gland Pharma Limited. The label displays the NDC code 68083-634-01, barcode, lot, and expiry date area with designated space for batch details, alongside regulatory designation 'Rx only.'*

FDA Label Image

Enoxaparin-spl-pfs-label-40-mg (Enoxaparin Spl Pfs Label 40 mg)

Label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL for subcutaneous injection. The label includes the NDC 68083-635-01 and indicates the manufacturer as Gland Pharma Limited. There is a designated area for batch details and lot/expiration information, with a barcode on the right side.*

FDA Label Image

Enoxaparin-spl-pfs-label-60mg (Enoxaparin Spl Pfs Label 60mg)

Label of Enoxaparin Sodium Injection, USP showing 60 mg/0.6 mL strength for subcutaneous injection. The label includes the Rx only designation, manufacturer Gland Pharma Limited, and placeholders for lot and expiration details alongside a barcode.*

FDA Label Image

Enoxaparin-spl-pfs-label-80mg (Enoxaparin Spl Pfs Label 80mg)

Label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL for subcutaneous injection. The label includes the NDC number 68083-637-01 and states it is manufactured by Gland Pharma Limited. The label indicates space for lot and expiration details and contains a barcode.*

FDA Label Image

Enoxaparin-spl-structure (Enoxaparin Spl Structure)

Chemical structure diagram showing the repeating disaccharide units of enoxaparin sodium, highlighting the presence of sodium carboxylate, hydroxyl groups, and variable substituents R1 and R2 on the sugar rings.*

FDA Label Image

Enoxaparin-spl-structure1 (Enoxaparin Spl Structure1)

Chemical structure diagram of enoxaparin sodium, showing its molecular composition with sodium, oxygen, and other atoms represented in a structural formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.